Zutshi N, Mohapatra B, Mondal P, An W, Goetz B, Wang S
iScience. 2024; 27(6):109912.
PMID: 38974465
PMC: 11225835.
DOI: 10.1016/j.isci.2024.109912.
Akbari M, Ghelichi-Ghojogh M, Nikeghbalian Z, Karami M, Akbari A, Hashemi M
Ann Med Surg (Lond). 2022; 84:104921.
PMID: 36536751
PMC: 9758373.
DOI: 10.1016/j.amsu.2022.104921.
Kozlov A
Infect Agent Cancer. 2022; 17(1):2.
PMID: 35012580
PMC: 8751115.
DOI: 10.1186/s13027-021-00412-0.
Flores-Huerta N, Silva-Cazares M, Arriaga-Pizano L, Prieto-Chavez J, Lopez-Camarillo C
Biomolecules. 2021; 11(3).
PMID: 33802575
PMC: 7998729.
DOI: 10.3390/biom11030380.
Castagnoli L, De Santis F, Volpari T, Vernieri C, Tagliabue E, Di Nicola M
Cells. 2020; 9(3).
PMID: 32120774
PMC: 7140486.
DOI: 10.3390/cells9030555.
The Notch system during pubertal development of the bovine mammary gland.
Bonadeo N, Becu-Villalobos D, Cristina C, Lacau-Mengido I
Sci Rep. 2019; 9(1):8899.
PMID: 31222104
PMC: 6586787.
DOI: 10.1038/s41598-019-45406-6.
Histology and Transcriptome Profiles of the Mammary Gland across Critical Windows of Development in Sprague Dawley Rats.
Gopalakrishnan K, Teitelbaum S, Wetmur J, Manservisi F, Falcioni L, Panzacchi S
J Mammary Gland Biol Neoplasia. 2018; 23(3):149-163.
PMID: 29956080
PMC: 6103804.
DOI: 10.1007/s10911-018-9401-7.
Zhi Zhen Fang formula reverses Hedgehog pathway mediated multidrug resistance in colorectal cancer.
Sui H, Duan P, Guo P, Hao L, Liu X, Zhang J
Oncol Rep. 2017; 38(4):2087-2095.
PMID: 28849164
PMC: 5652964.
DOI: 10.3892/or.2017.5917.
Downregulation of Bmi1 in breast cancer stem cells suppresses tumor growth and proliferation.
Srinivasan M, Bharali D, Sudha T, Khedr M, Guest I, Sell S
Oncotarget. 2017; 8(24):38731-38742.
PMID: 28418883
PMC: 5503567.
DOI: 10.18632/oncotarget.16317.
Tumor-associated myeloid cells as guiding forces of cancer cell stemness.
Sica A, Porta C, Amadori A, Pasto A
Cancer Immunol Immunother. 2017; 66(8):1025-1036.
PMID: 28401258
PMC: 11029054.
DOI: 10.1007/s00262-017-1997-8.
Anti-cancer stem cell activity of a hedgehog inhibitor GANT61 in estrogen receptor-positive breast cancer cells.
Kurebayashi J, Koike Y, Ohta Y, Saitoh W, Yamashita T, Kanomata N
Cancer Sci. 2017; 108(5):918-930.
PMID: 28211214
PMC: 5448645.
DOI: 10.1111/cas.13205.
c-Jun N-terminal kinase promotes stem cell phenotype in triple-negative breast cancer through upregulation of Notch1 via activation of c-Jun.
Xie X, Kaoud T, Edupuganti R, Zhang T, Kogawa T, Zhao Y
Oncogene. 2016; 36(18):2599-2608.
PMID: 27941886
PMC: 6116358.
DOI: 10.1038/onc.2016.417.
TRIM28 multi-domain protein regulates cancer stem cell population in breast tumor development.
Czerwinska P, Shah P, Tomczak K, Klimczak M, Mazurek S, Sozanska B
Oncotarget. 2016; 8(1):863-882.
PMID: 27845900
PMC: 5352203.
DOI: 10.18632/oncotarget.13273.
Tamoxifen Resistance: Emerging Molecular Targets.
Rondon-Lagos M, Villegas V, Rangel N, Sanchez M, Zaphiropoulos P
Int J Mol Sci. 2016; 17(8).
PMID: 27548161
PMC: 5000752.
DOI: 10.3390/ijms17081357.
The Potential Role of Hedgehog Signaling in the Luminal/Basal Phenotype of Breast Epithelia and in Breast Cancer Invasion and Metastasis.
Flemban A, Qualtrough D
Cancers (Basel). 2015; 7(3):1863-84.
PMID: 26389956
PMC: 4586799.
DOI: 10.3390/cancers7030866.
Cancer microenvironment, inflammation and cancer stem cells: A hypothesis for a paradigm change and new targets in cancer control.
Blaylock R
Surg Neurol Int. 2015; 6:92.
PMID: 26097771
PMC: 4455122.
DOI: 10.4103/2152-7806.157890.
The role of Sox9 in mouse mammary gland development and maintenance of mammary stem and luminal progenitor cells.
Malhotra G, Zhao X, Edwards E, Kopp J, Naramura M, Sander M
BMC Dev Biol. 2014; 14:47.
PMID: 25527186
PMC: 4297388.
DOI: 10.1186/s12861-014-0047-4.
Systemic approaches identify a garlic-derived chemical, Z-ajoene, as a glioblastoma multiforme cancer stem cell-specific targeting agent.
Jung Y, Park H, Zhao H, Jeon R, Ryu J, Kim W
Mol Cells. 2014; 37(7):547-53.
PMID: 25078449
PMC: 4132307.
DOI: 10.14348/molcells.2014.0158.
Syndecan-1 (CD138) modulates triple-negative breast cancer stem cell properties via regulation of LRP-6 and IL-6-mediated STAT3 signaling.
Ibrahim S, Hassan H, Vilardo L, Kumar S, Vijaya Kumar A, Kelsch R
PLoS One. 2014; 8(12):e85737.
PMID: 24392029
PMC: 3877388.
DOI: 10.1371/journal.pone.0085737.
The Hedgehog inhibitor cyclopamine antagonizes chemoresistance of breast cancer cells.
Chai F, Zhou J, Chen C, Xie S, Chen X, Su P
Onco Targets Ther. 2013; 6:1643-7.
PMID: 24250231
PMC: 3829677.
DOI: 10.2147/OTT.S51914.